1,800 Seconds™ in the Diagnosis of Idiopathic Pulmonary Fibrosis: A Multidisciplinary Approach
May 2, 2018
May 2, 2019
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Postgraduate Institute for Medicine and Catamount Medical Education.
Supported by an educational grant from Boehringer Ingelheim.
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity has been designed to meet the educational needs of pulmonologists, radiologists, primary care physicians, PAs, nurse practitioners, nurses, and other healthcare professionals involved in the diagnosis of idiopathic pulmonary fibrosis (IPF).
Upon completion of this activity, participants should be able to:
- Implement guideline-driven approaches to identify IPF while avoiding the unnecessary risk of morbidity and mortality in the patient population
- Utilize multidisciplinary evaluation when diagnosing IPF
- Differentiate between definite, probable, and possible IPF
Imre Noth, MD
Dudley F. Rochester Professor of Medicine
Chief, Division of Pulmonary and Critical Care Medicine
University of Virginia
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Catamount Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Imre Noth, MD
- Royalty: UpToDate
- Consulting fees: Boehringer Ingelheim, Genentech, Global Blood Tech, Sanofi
- Speakers’ bureau and other non-CME service fees: Boehringer Ingelheim, Genentech
- Contracted Research: Boehringer Ingelheim, Genentech
Planners and Managers
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.
The Catamount Medical Education planners and managers, Susan Denner, MD, MS, and Jennifer Green, have nothing to disclose.
Method of Participation
There are no fees for participating and receiving credit for this activity. During the period April 30, 2018, through April 30, 2019, participants must:
- Read the learning objectives and disclosures
- Study the educational activity
- Complete the post-test and the evaluation form
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on Submit Post-test at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 75% or higher), your certificate will be made available immediately. Click on "View Certificate" and print the certificate for your records. If you receive a score of 74% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The podcast may be downloaded here: